- Home
- SKIL vs SER Comparison
SKIL vs SER Comparison
Compare SKIL & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKIL
- SER
- Stock Information
- Founded
- SKIL 1998
- SER 2017
- Country
- SKIL United States
- SER United States
- Employees
- SKIL N/A
- SER N/A
- Industry
- SKIL Computer Software: Prepackaged Software
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- SKIL Technology
- SER Health Care
- Exchange
- SKIL Nasdaq
- SER Nasdaq
- Market Cap
- SKIL 131.3M
- SER 61.5M
- IPO Year
- SKIL N/A
- SER 2018
- Fundamental
- Price
- SKIL $16.09
- SER $7.71
- Analyst Decision
- SKIL Strong Buy
- SER
- Analyst Count
- SKIL 4
- SER 0
- Target Price
- SKIL $36.67
- SER N/A
- AVG Volume (30 Days)
- SKIL 50.8K
- SER 21.6K
- Earning Date
- SKIL 12-03-2024
- SER 08-09-2024
- Dividend Yield
- SKIL N/A
- SER N/A
- EPS Growth
- SKIL N/A
- SER N/A
- EPS
- SKIL N/A
- SER N/A
- Revenue
- SKIL $536,511,999.00
- SER $3,172,500.00
- Revenue This Year
- SKIL N/A
- SER N/A
- Revenue Next Year
- SKIL $3.46
- SER N/A
- P/E Ratio
- SKIL N/A
- SER N/A
- Revenue Growth
- SKIL N/A
- SER 2368.87
- 52 Week Low
- SKIL $5.09
- SER $5.85
- 52 Week High
- SKIL $20.87
- SER $25.00
- Technical
- Relative Strength Index (RSI)
- SKIL 61.57
- SER 57.44
- Support Level
- SKIL $15.12
- SER $6.76
- Resistance Level
- SKIL $16.15
- SER $8.14
- Average True Range (ATR)
- SKIL 0.73
- SER 0.51
- MACD
- SKIL -0.00
- SER 0.12
- Stochastic Oscillator
- SKIL 88.33
- SER 79.62
About SKIL Skillsoft Corp.
Skillsoft Corp is a leader in corporate digital learning. The company's segment includes Content & Platform and Instructor-Led Training. The Content & Platform business engages in the sale, marketing and delivery of its content learning solutions, in areas such as Leadership and Business, Technology and Developer and Compliance. The Instructor-Led Training business offers training solutions covering information technology and business skills for corporations and their employees. The majority of revenue is from the Content & Platform segment.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.